Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.83 Analyst target: $3.00 Upside: 263.42%
iSpecimen, Inc. provides technology that connects life science researchers in need of human biofluids, tissues and living cells for their research with biospecimens available from healthcare provider organizations globally. The company is headquartered in Lexington, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.